Yes, muscular dystrophy (MD) can affect vision, but it depends on the type; some forms like Oculopharyngeal MD (OPMD) directly impact eye muscles causing droopy eyelids (ptosis), while Myotonic Dystrophy (DM) often causes early cataracts, and FSHD might affect the retina, but general MD usually spares eyesight, making regular eye checks important.
What is oculopharyngeal muscular dystrophy? Oculopharyngeal muscular dystrophy (OPMD) is a rare genetic condition. It causes weakness in the muscles around the upper eyelids and part of the throat called the pharynx. The condition may affect vision and cause problems swallowing and talking.
Ocular myasthenia gravis only affects the muscles that move the eyes and eyelids. The symptoms of ocular myasthenia gravis include double vision (seeing two images instead of one), trouble focusing, and drooping eyelids.
Fuchs dystrophy is a condition in which fluid builds up in the clear tissue at the front of the eye, called the cornea. This causes your cornea to swell and thicken, leading to glare, blurred or cloudy vision, and eye discomfort. Fuchs (fewks) dystrophy usually affects both eyes.
Symptoms of muscular dystrophy
Polymyositis is sometimes mistaken for muscular dystrophy, so careful diagnosis is important.
A doctor may order a blood test that can detect elevated levels of creatine kinase, an enzyme released into the bloodstream when muscle fibers deteriorate. Elevated levels of this enzyme mean the muscle is being destroyed due to an abnormal process, such as muscular dystrophy or an inflammatory muscle disease.
These are the 'big four': macular degeneration, diabetic eye disease, glaucoma and cataracts. How do these four conditions affect our sight? Macular degeneration means deposits around the macular (middle) part of the eye. Diabetes causes changes in the blood vessels, which can lead to bleeding or leaking.
Until recently, children with Duchenne muscular dystrophy (DMD) did not often live beyond their teens. However, improvements in cardiac and respiratory care mean that life expectancy is increasing, with many DMD patients reaching their 30s, and some living into their 40s and 50s.
Muscle eye brain disease (MEB) belongs to a group of genetic, degenerative muscular disorders (congenital muscular dystrophies). Individuals with this condition have muscle weakness (hypotonia), severe nearsightedness (myopia), glaucoma, and brain abnormalities.
Symptoms commonly associated with myasthenia gravis include: Weakness of the eye muscles (ocular myasthenia) Drooping of one or both eyelids (ptosis) Blurred or double vision (diplopia)
Your eyelids may droop, or you may not be able to keep your eyes open. Some people have double vision. Eye weakness is often the first sign of myasthenia. Ocular myasthenia gravis may evolve into the generalized form for nearly half of all people diagnosed with this type.
MYASTHENIC CRISES
The 20-30-40 rule can be used to determine which patients may need airway management. The values are a vital capacity less than 20 mL/kg, a negative inspiratory force less than -30 cm H 2O, or a maximal expiratory pressure less than 40 cm H 2O.
Symptoms of oculopharyngeal muscular dystrophy
Myotonic dystrophy is an autosomal dominant disease that causes muscle weakness, atrophy and myotonia. The most common ocular findings are Christmas tree cataracts, ptosis, lower IOP, FECD and reticular maculopathies, with a rare occurrence of choroidal melanoma.
Common symptoms include weakness in the hips, shoulders, and upper arms, difficulty standing up from a seated position, and muscle pain. In some cases, individuals with adult-onset MD may also experience difficulty breathing or swallowing. Treatment focuses on managing symptoms and improving quality of life.
End stage cardio-respiratory failure is the most common cause of death in DMD. Young unexpected deaths do still occur. Vigilance is needed for nutritional, respiratory and cardiac failure at any age.
Depending on the type, muscular dystrophy can affect your ability to move, walk and perform daily activities. It can also affect muscles that help your heart and lungs function. Some forms of muscular dystrophy are present at birth or develop during childhood.
Corticosteroids. Corticosteroids, such as prednisone, are powerful anti-inflammatory medications often prescribed for people with Duchenne muscular dystrophy or Becker muscular dystrophy. These medications can help to delay muscle degeneration and retain strength. Corticosteroids can also prolong the ability to walk.
In its more severe forms, vitamin A deficiency contributes to blindness by making the cornea very dry, thus damaging the retina and cornea. An estimated 250 000–500 000 children who are vitamin A-deficient become blind every year, and half of them die within 12 months of losing their sight.
The leading causes of blindness and low vision in the United States are primarily age-related eye diseases. Those diseases include age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma.
Most eye floaters are caused by age-related changes that occur as the jelly-like substance (vitreous) inside your eyes liquifies and contracts. Scattered clumps of collagen fibers form within the vitreous and can cast tiny shadows on your retina. The shadows you see are called floaters.
Muscle MRI has become a useful tool in the diagnosis of patients with muscle dystrophies. The standardization of the study protocols has allowed obtaining information from many patients with different muscle diseases.
Your healthcare team might recommend medicines such as: Corticosteroids. These medicines can help with muscle strength and slow some types of muscular dystrophy from becoming worse. Examples of corticosteroids include prednisone and deflazacort (Emflaza).
These muscular dystrophies affect 50 percent of male infants of mothers who carry the genetic defect; this is called X-linked recessive inheritance. Females who inherit their mother's defective X chromosome (called carrier females) are usually disease free, although mild symptoms can occur occasionally (figure 2).